Today

Agents

Chat

Arena

Discover

More

App

Merck, Daiichi Sankyo withdraw US application for lung cancer drug - MRK News | Rallies

Merck, Daiichi Sankyo withdraw US application for lung cancer drug

MRK•2026-09-25

Merck and Daiichi Sankyo voluntarily withdrew their US application seeking accelerated approval for their experimental lung cancer therapy.

1. Application withdrawn

Merck and Daiichi Sankyo said they voluntarily withdrew their US application seeking accelerated approval for their experimental lung cancer therapy.

Related News

Nasdaq trade halt continues, with news pending at 8:59 p.m.

FBGL•2026-09-26

Exxon Mobil Joliet refinery resumes operations nearly two weeks after power outage

XOM•2026-09-26

Nasdaq trade halt continues, with news pending at 03:28 a.m.

2026-09-26

Nasdaq trade halt continues, news pending at 08:59 p.m.

IMMP•2026-09-26

Platinum Analytics shares face Nasdaq suspension after panel upholds delisting decision

PLTS•2026-09-26